IFC plans ₹303.9 cr investment in A91 Partners’ third fund
The International Finance Corporation (IFC), the private lending arm of the World Bank, is planning an equity investment of up to about ₹303.9 crore into the venture capital firm A91 Partners’ third fund. This significant investment is expected to strengthen the venture capital ecosystem in India, particularly in the technology and healthcare sectors.
According to a disclosure, IFC is also considering an additional co-investment of up to ₹260.5 crore into the new fund. This additional investment will enable A91 Partners to make more strategic investments in Indian startups, further accelerating the growth of the country’s startup ecosystem.
A91 Partners is a well-established venture capital firm in India, with a strong track record of investing in innovative startups. The firm’s third fund, which is expected to close soon, has already received commitments from other investors. The IFC’s investment will be a significant boost to the fund, enabling it to make more investments in the most promising Indian startups.
The IFC’s investment in A91 Partners’ third fund is part of its broader strategy to support the growth of the startup ecosystem in India. The organization has been actively promoting entrepreneurship and innovation in the country, and has invested in several Indian startups in the past.
In recent years, India has emerged as one of the fastest-growing startup ecosystems in the world. The country has seen a surge in the number of startups, particularly in the technology and healthcare sectors. The government has also been actively promoting entrepreneurship and innovation, through initiatives such as the Startup India program and the Atal Innovation Mission.
Despite the progress made, the startup ecosystem in India still faces several challenges, including limited access to capital and a lack of talent. The IFC’s investment in A91 Partners’ third fund is expected to help address these challenges, by providing more capital to Indian startups and enabling them to scale more quickly.
A91 Partners has a strong track record of investing in successful Indian startups. The firm’s portfolio companies include several well-known brands, such as PolicyBazaar, PharmEasy, and CureFit. The firm’s investments have been focused on the technology and healthcare sectors, which are among the most promising areas of growth in India.
The IFC’s investment in A91 Partners’ third fund is expected to have several benefits for the Indian startup ecosystem. Firstly, it will provide more capital to Indian startups, enabling them to scale more quickly and achieve greater success. Secondly, it will help to promote entrepreneurship and innovation in India, by providing a platform for startups to access capital and resources.
In conclusion, the IFC’s plan to invest ₹303.9 crore in A91 Partners’ third fund is a significant development for the Indian startup ecosystem. The investment will provide more capital to Indian startups, promote entrepreneurship and innovation, and help to strengthen the venture capital ecosystem in India.
Source: https://inc42.com/buzz/ifc-mulls-65-mn-investment-in-a91-partners-third-fund/
